Novum Pharma Opens $53M Del. Ch. 11 With Sale Plan
Specialty drug company Novum Pharma LLC opened a Chapter 11 case in Delaware on Sunday with $53 million in debt and sale plans, citing pressure from generic product competitors, manufacturing issues...To view the full article, register now.
Already a subscriber? Click here to view full article